311
|
|
|
Inflammation and lipid regulator with UBA-like and NBR1-like domains |
C6orf106, FP852, dJ391O22.4 |
|
312
|
|
|
IQ motif containing H |
NYDSP5 |
|
313
|
|
|
ISL LIM homeobox 2 |
- |
|
314
|
|
|
Intercellular adhesion molecule 5 |
TLCN, TLN |
|
315
|
|
|
INS-IGF2 readthrough |
INSIGF |
Ankylosing spondylitis, Arthritis, Autoimmune diseases, Autoimmune thyroiditis, Celiac disease, Common variable immunodeficiency, Crohn disease, Diabetes mellitus, Growth restriction, severe, with distinctive facies, Hyperglycemia, Hyperproinsulinemia, Autoimmune diabetes, Liver carcinoma, Lupus erythematosus, Mason type diabetes, Monogenic diabetes, Multiple sclerosis, Psoriasis, Russell-silver syndrome, Ulcerative colitisView all (5 more) |
316
|
|
|
Interactor of little elongation complex ELL subunit 2 pseudogene 2 |
NARG2P2 |
|
317
|
|
|
Interleukin 1 receptor type 2 |
CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB |
|
318
|
|
|
Iroquois homeobox 3 |
IRX-1, IRXB1 |
|
319
|
|
|
Iroquois homeobox 1 |
IRX-5, IRXA1 |
|
320
|
|
|
Interactor of little elongation complex ELL subunit 2 |
BRCC1, NARG2 |
|